<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The role of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in etiopathogenesis of vasospasm is not clearly understood yet </plain></SENT>
<SENT sid="1" pm="."><plain>It is widely accepted that protection of the endothelial cells from the process of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> could have beneficial effects on <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> after <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> (SAH) </plain></SENT>
<SENT sid="2" pm="."><plain>Mexiletine blocks <z:chebi fb="199" ids="26708">sodium</z:chebi> and calcium channels and activates ATP-sensitive <z:chebi fb="0" ids="29103">K(+)</z:chebi> channels </plain></SENT>
<SENT sid="3" pm="."><plain>Moreover, mexiletine is known to have potent <z:chebi fb="11" ids="22586">antioxidant</z:chebi> effects through inhibiting <z:chebi fb="19" ids="26519">free-radical</z:chebi> production </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: Twenty-one rabbits were allocated into three groups randomly </plain></SENT>
<SENT sid="5" pm="."><plain>Group I was sham operated group (n=7) </plain></SENT>
<SENT sid="6" pm="."><plain>SAH occurred but no medication was given to the Group II rabbits (SAH only group) (n=7) </plain></SENT>
<SENT sid="7" pm="."><plain>Mexiletine (50 mg/kg, b.i.d., i.p.) was administered just before SAH and continued until 48 hours following SAH to the Group III rabbits (Mexiletine treated group) (n=7) </plain></SENT>
<SENT sid="8" pm="."><plain>The ApopTag peroxidase in situ <z:mpath ids='MPATH_3'>apoptosis</z:mpath> detection kit (Serologicals Corporation, former Intergen) was used to demonstrate <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in a cross section of basillary arteries </plain></SENT>
<SENT sid="9" pm="."><plain><z:chebi fb="0" ids="33202">Thiobarbituric acid</z:chebi> reactive material was used to determine the <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation levels </plain></SENT>
<SENT sid="10" pm="."><plain>RESULTS: There was a statistically significant difference between <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation product levels of the control and SAH only groups (p&lt;0.05) </plain></SENT>
<SENT sid="11" pm="."><plain>The level of <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation production in Mexiletine treated group was significantly lower compared with SAH only group (p&lt;0.05) but not significantly higher than the control group (p&gt;0.05) </plain></SENT>
<SENT sid="12" pm="."><plain>DISCUSSION: In the present study we investigated the <z:chebi fb="11" ids="22586">antioxidant</z:chebi> action of mexiletine on <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of endothelium following a rabbit SAH model </plain></SENT>
<SENT sid="13" pm="."><plain>This experimental study directly suggested that <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation is an important step in development of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in endothelial cells and prevention of structural integrity of endothelial cell should play a beneficial role in attenuation of <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> </plain></SENT>
<SENT sid="14" pm="."><plain>Mexiletine treatment prevented the increase in <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation and <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> </plain></SENT>
<SENT sid="15" pm="."><plain>Examination of endothelial cells by staining specific for <z:mpath ids='MPATH_3'>apoptosis</z:mpath> demonstrated significant protection of cell integrity in the treated group </plain></SENT>
</text></document>